{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:44:57Z","timestamp":1791398697624,"version":"4.3.3"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.iac.2024.07.005","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T11:36:11Z","timestamp":1723894571000},"page":"657-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Biologics in Chronic Rhinosinusitis"],"prefix":"10.1016","volume":"44","author":[{"given":"Jacob T.","family":"Boyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashoke R.","family":"Khanwalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"September 2015","key":"10.1016\/j.iac.2024.07.005_bib1","first-page":"S22","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis","volume":"6","author":"Orlandi","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.iac.2024.07.005_bib2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/0194599818774006","article-title":"Prevalence of potential adult chronic rhinosinusitis symptoms in the United States","volume":"159","author":"Bhattacharyya","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/all.13042","article-title":"Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample","volume":"72","author":"Hirsch","year":"2017","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2500\/ajra.2016.30.4297","article-title":"Chronic rhinosinusitis: epidemiology and burden of disease","volume":"30","author":"DeConde","year":"2016","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"10.1016\/j.iac.2024.07.005_bib5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jaci.2018.12.986","article-title":"Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology","volume":"143","author":"Dietz de Loos","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/coa.13971","article-title":"Epidemiology and aetiology of chronic rhinosinusitis in Asia-A narrative review","volume":"48","author":"Chee","year":"2023","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.iac.2024.07.005_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoto.2020.1453","article-title":"Contemporary classification of chronic rhinosinusitis beyond polyps vs no polyps: a review","author":"Grayson","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.iac.2024.07.005_bib9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jaip.2019.12.021","article-title":"Phenotypes of chronic rhinosinusitis","volume":"8","author":"Cho","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib10","first-page":"132","article-title":"Endotyping chronic rhinosinusitis with nasal polyps: understanding inflammation beyond phenotypes","volume":"37","author":"Chen","year":"2023"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.anai.2018.10.014","article-title":"Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes","volume":"122","author":"Cao","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.iac.2024.07.005_bib12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaci.2015.10.010","article-title":"Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis","volume":"136","author":"Bachert","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2024.07.005_bib13","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jaip.2017.04.024","article-title":"Biotherapeutics in chronic rhinosinusitis with and without nasal polyps","volume":"5","author":"Bachert","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"9643","key":"10.1016\/j.iac.2024.07.005_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.iac.2024.07.005_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","article-title":"The 3 major types of innate and adaptive cell-mediated effector immunity","volume":"135","author":"Annunziato","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2024.07.005_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.anai.2020.01.013","article-title":"Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis","volume":"124","author":"Staudacher","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"10.1016\/j.iac.2024.07.005_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T\u00a0cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"Suppl","key":"10.1016\/j.iac.2024.07.005_bib18","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"29","author":"Fokkens","year":"2020","journal-title":"Official Journal of the European and International Rhinologic Societies and of the Confederation of European ORL-HNS."},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-017-0157-8","article-title":"Endotype-driven treatment in chronic upper airway diseases","volume":"7","author":"De Greve","year":"2017","journal-title":"Clin Transl Allergy"},{"issue":"7","key":"10.1016\/j.iac.2024.07.005_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0011450","article-title":"Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis","volume":"5","author":"Plager","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.iac.2024.07.005_bib21","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/all.12440","article-title":"Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis","volume":"69","author":"Miljkovic","year":"2014","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2024.07.005_bib22","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.jaci.2013.12.1092","article-title":"Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity","volume":"133","author":"Mahdavinia","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.iac.2024.07.005_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1164\/rccm.201212-2227OC","article-title":"IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps","volume":"188","author":"Shaw","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib25","first-page":"1","article-title":"Clinically relevant phenotypes in chronic rhinosinusitis","volume":"48","author":"Grayson","year":"2019","journal-title":"J\u00a0Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.iac.2024.07.005_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1945892418779451","article-title":"Systemic predictors of eosinophilic chronic rhinosinusitis","volume":"32","author":"Ho","year":"2018","journal-title":"Am J Rhinol Allergy."},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1808-8694(15)31090-9","article-title":"Histological aspects of rhinosinusal polyps","volume":"74","author":"Couto","year":"2008","journal-title":"Braz J Otorhinolaryngol"},{"issue":"8","key":"10.1016\/j.iac.2024.07.005_bib28","first-page":"2812","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.iac.2024.07.005_bib29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: The JESREC Study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2024.07.005_bib30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T\u00a0cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2024.07.005_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2008.07.008","article-title":"Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease","volume":"122","author":"Zhang","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2024.07.005_bib32","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2024.07.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0097581","article-title":"Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps","volume":"9","author":"Derycke","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.iac.2024.07.005_bib34","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.jaip.2023.05.011","article-title":"The unified airway hypothesis: evidence from specific intervention with anti-il-5 biologic therapy","volume":"11","author":"Bachert","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0171047","article-title":"Impact of chronic rhinosinusitis on severe asthma patients","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.iac.2024.07.005_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2500\/ajra.2011.25.3613","article-title":"Association between severity of asthma and degree of chronic rhinosinusitis","volume":"25","author":"Lin","year":"2011","journal-title":"Am J Rhinol Allergy."},{"issue":"5","key":"10.1016\/j.iac.2024.07.005_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.05.042","article-title":"Regional differences in the expression of innate host defense molecules in sinonasal mucosa","volume":"132","author":"Seshadri","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaci.2016.06.063","article-title":"Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois","volume":"139","author":"Tan","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2024.07.005_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2008.02.018","article-title":"T-cell regulation in chronic paranasal sinus disease","volume":"121","author":"Van Bruaene","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOO.0000000000000425","article-title":"The role of frontal sinus drillouts in nasal polyposis","volume":"26","author":"Orgain","year":"2018","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"9","key":"10.1016\/j.iac.2024.07.005_bib41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/alr.21172","article-title":"Distribution of topical agents to the paranasal sinuses: An evidence-based review with recommendations","volume":"3","author":"Thomas","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"issue":"0","key":"10.1016\/j.iac.2024.07.005_bib42","doi-asserted-by":"crossref","DOI":"10.4193\/Rhin20.073","article-title":"Systemic medication requirement in post-surgical patients with eosinophilic chronic rhinosinusitis","volume":"0","author":"Ho","year":"2020","journal-title":"Rhinology journal"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clim.2014.09.007","article-title":"Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness","volume":"155","author":"Walford","year":"2014","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.otc.2023.08.006","article-title":"Current and novel biologic therapies for patients with asthma and nasal polyps","volume":"57","author":"Mandl","year":"2024","journal-title":"Otolaryngol Clin North Am"},{"issue":"3","key":"10.1016\/j.iac.2024.07.005_bib45","first-page":"194","article-title":"EPOS\/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.iac.2024.07.005_bib46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm.2754","article-title":"Therapies for allergic inflammation: Refining strategies to induce tolerance","volume":"18","author":"Akdis","year":"2012","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.iac.2024.07.005_bib47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: A randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.iac.2024.07.005_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2016.04.002","article-title":"Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box","volume":"32","author":"Ul-Haq","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2022.04.007","article-title":"Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease","volume":"150","author":"Buchheit","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2024.07.005_bib50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.iac.2024.07.005_bib51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2024.07.005_bib52","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/all.15434","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In-depth sinus surgery analysis","volume":"78","author":"Fokkens","year":"2023","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2003.11.044","article-title":"Omalizumab rapidly decreases nasal allergic response and Fc\u03b5RI on basophils","volume":"113","author":"Lin","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2024.07.005_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2024.07.005_bib55","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaci.2004.07.013","article-title":"Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis","volume":"114","author":"Van Zele","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2024.07.005_bib56","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2024.07.005_bib58","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.anai.2019.08.077","article-title":"Omalizumab efficacy and safety in nasal polyposis: results from two parallel, double-blind, placebo-controlled trials","volume":"123","author":"Gevaert","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2024.07.005_bib59","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/alr.21835","article-title":"Middle turbinate edema as a diagnostic marker of inhalant allergy","volume":"7","author":"Hamizan","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.iac.2024.07.005_bib61","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0194599817711887","article-title":"Polypoid change of the middle turbinate and paranasal sinus polyposis are distinct entities","volume":"157","author":"Brunner","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"8","key":"10.1016\/j.iac.2024.07.005_bib62","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/alr.22951","article-title":"Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"12","author":"Dharmarajan","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/alr.23059","article-title":"A\u00a0comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis","volume":"13","author":"Miglani","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.iac.2024.07.005_bib64","first-page":"1","article-title":"Biologics versus functional endoscopic sinus surgery for the treatment of chronic rhinosinusitis with nasal polyps: a literature review","author":"Alshatti","year":"2023","journal-title":"J\u00a0Laryngol Otol"},{"issue":"6","key":"10.1016\/j.iac.2024.07.005_bib65","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/alr.22936","article-title":"Economic evaluation of dupilumab versus endoscopic sinus surgery for the treatment of chronic rhinosinusitis with nasal polyps","volume":"12","author":"Parasher","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib66","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1002\/lary.28648","article-title":"Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"131","author":"Scangas","year":"2021","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib67","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/all.15134","article-title":"Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps","volume":"77","author":"Lans","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2024.07.005_bib68","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.17116\/otorino20218602143","article-title":"[Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma]","volume":"86","author":"Boiko","year":"2021","journal-title":"Vestn Otorinolaringol"},{"issue":"2","key":"10.1016\/j.iac.2024.07.005_bib70","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bcp.15002","article-title":"A\u00a0Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma","volume":"88","author":"Singh","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.iac.2024.07.005_bib71","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2147\/JAA.S413064","article-title":"Tezepelumab efficacy in patients with severe, uncontrolled asthma with comorbid nasal polyps in NAVIGATOR","volume":"16","author":"Laidlaw","year":"2023","journal-title":"J\u00a0Asthma Allergy"},{"issue":"3","key":"10.1016\/j.iac.2024.07.005_bib72","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01193-2022","article-title":"Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma","volume":"61","author":"Gauvreau","year":"2023","journal-title":"Eur Respir J"},{"issue":"Supplement_2","key":"10.1016\/j.iac.2024.07.005_bib73","doi-asserted-by":"crossref","first-page":"ii59","DOI":"10.1093\/bjd\/ljad498.061","article-title":"565 \u2013 Safety and pharmacokinetic profiles of a humanized monoclonal antibody TQH2722 targeting interleukin 4 receptor alpha (IL-4R\u03b1) in health adult subjects","volume":"190","author":"Lin","year":"2024","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2024.07.005_bib74","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12552","article-title":"IL-33: biological properties, functions and roles in airway disease","volume":"278","author":"Drake","year":"2017","journal-title":"Immunol Rev"},{"issue":"515","key":"10.1016\/j.iac.2024.07.005_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2945","article-title":"Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis","volume":"11","author":"Chen","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.iac.2024.07.005_bib76","author":"Danto","year":"2023","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.iac.2024.07.005_bib77","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Study of brodalumab , a human anti \u2013 il-17 receptor monoclonal antibody , in moderate to severe asthma","volume":"188","author":"Busse","year":"2013","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856124000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856124000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T12:39:42Z","timestamp":1728391182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856124000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0889856124000547"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2024.07.005","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologics in Chronic Rhinosinusitis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2024.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}